Docs Told to Avoid Financial Ties to Drug Research

Physicians’ financial interests should not overtake the needs of a patient when it comes to dealing with drug and medical device manufacturers.  This was the obvious conclusion arrived at by a group of bio-ethicists at a conference hosted by Cleveland Clinic and sponsored by the National Institutes of Health.  The recent spate of ethical issues over doctors’ involvment with drug and device approval has raised ethical questions within the medical community.